Nuclear Medicine and Biology:
Official Journal of the SRS
Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers. The importance of the target to an unmet clinical need should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.
July - August 2018 Issue (Vol. 62-63) Table of Contents
The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates
Wen Jiang, David Ulmert, Brian W. Simons, Diane S. Abou, Daniel L.J. Thorek
Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents Ole Tietz, Alison Marshall, Cody Bergman, Melinda Wuest, Frank Wuest
Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors Ganesan Vaidyanathan, Choong Mo Kang, Darryl McDougald, Il Minn, Mary Brummet, Martin G. Pomper, Michael R. Zalutsky
What about α v β 3 integrins in molecular imaging in oncology? Frederic Debordeaux, Lucie Chansel-Debordeaux, Jean-Baptiste Pinaquy, Philippe Fernandez, Jurgen Schulz
Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent Jyotsna Bhatt, Archana Mukherjee, Ajit Shinto, Kamaleshwaran Koramadai Karuppusamy, Aruna Korde, Mukesh Kumar, Haladhar Dev Sarma, Krishnamohan Repaka, Ashutosh Dash
99mTc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging Farzaneh Rezazadeh, Nourollah Sadeghzadeh, Seyed Mohammad Abedi, Saeid Abediankenari
One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging Falguni Basuli, Xiang Zhang, Mark R. Williams, Jurgen Seidel, Michael V. Green, Peter L. Choyke, Rolf E. Swenson, Elaine M. Jagoda
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer Nilantha Bandara, Tamila J. Stott Reynolds, Rebecca Schehr, Rajendra P. Bandari, Philipp J. Diebolder, Stephanie Krieger, Jingli Xu, Yubin Miao, Buck E. Rogers, Charles J. Smith
To gain complimentary access to the January 2018 issue, please select the image above.
To access the journal home page, click here.
To access instructions for authors and related content, click here.
If you are a member and experiencing difficulty accessing the journal online, please email Michael Bonds [M.Bonds(a)elsevier.com)]. Michael is our society liaison and typically responds in under 24 hours. You may also email our Executive Director, Charles Metzger [cmetzger(a)srsweb.org].